Literature DB >> 19404778

The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma.

Mudan Lu1, Jianbo Ma, Wenqun Xue, Chun Cheng, You Wang, Yueming Zhao, Qing Ke, Haiou Liu, Yonghua Liu, Peng Li, Xiaopeng Cui, Song He, Aiguo Shen.   

Abstract

The forkhead box proteins (FOXO proteins) comprise a large family of functionally diverse transcription factors involved in cellular proliferation, transformation, differentiation and longevity. Recently, ubiquitination and proteasome degradation of FOXO3a have been reported. In this study, we investigated the role of FOXO3a and Skp2 in human hepatocellular carcinoma progression. Immunohistochemical analysis was performed on formalin-fixed paraffin sections of 91 specimens. Furthermore in vitro, western-blot analysis and protein stabilization studies were used to study the relationship between FOXO3a and Skp2. We found that the expression of FOXO3a was negatively related with Skp2 expression (r = -0.583; p < 0.05) and FOXO3a expression correlated significantly with histological grade (p = 0.000), cirrhosis (p = 0.015), and tumor size (p = 0.043) while Skp2 expression correlated significantly with histological grade (p = 0.000) and tumor size (p = 0.005). Kaplan-Meier analysis revealed that survival curves of low versus high expressers of FOXO3a and Skp2 showed a highly significant separation in HCC (p < 0.01). Our results suggested that FOXO3a and Skp2 may be considered to be important prognosis in human hepatocellular carcinoma. In vitro studies suggested that the degradation of FOXO3a may dependent on the expression of Skp2 in the proliferated Huh7 cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19404778     DOI: 10.1007/s12253-009-9171-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  25 in total

1.  Estimating the world cancer burden: Globocan 2000.

Authors:  D M Parkin; F Bray; J Ferlay; P Pisani
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

2.  Hepatocyte nuclear factor 3/fork head or "winged helix" proteins: a family of transcription factors of diverse biologic function.

Authors:  E Lai; K L Clark; S K Burley; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

3.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

Authors:  Haojie Huang; Kevin M Regan; Fang Wang; Diping Wang; David I Smith; Jan M A van Deursen; Donald J Tindall
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

Review 4.  FOXO transcription factors at the interface between longevity and tumor suppression.

Authors:  Eric L Greer; Anne Brunet
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

5.  Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily.

Authors:  M J Anderson; C S Viars; S Czekay; W K Cavenee; K C Arden
Journal:  Genomics       Date:  1998-01-15       Impact factor: 5.736

Review 6.  Epidemiology of hepatocellular carcinoma.

Authors:  H B el-Serag
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

7.  Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway.

Authors:  M V Chakravarthy; T W Abraha; R J Schwartz; M L Fiorotto; F W Booth
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

8.  Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.

Authors:  Xundi Xu; Hirofumi Yamamoto; Masato Sakon; Masayoshi Yasui; Chew Yee Ngan; Hiroki Fukunaga; Tetsushi Morita; Minoru Ogawa; Hiroaki Nagano; Shoji Nakamori; Mitsugu Sekimoto; Nariaki Matsuura; Morito Monden
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

9.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma.

Authors:  N Galili; R J Davis; W J Fredericks; S Mukhopadhyay; F J Rauscher; B S Emanuel; G Rovera; F G Barr
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

10.  FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons.

Authors:  Jonathan Gilley; Paul J Coffer; Jonathan Ham
Journal:  J Cell Biol       Date:  2003-08-11       Impact factor: 10.539

View more
  22 in total

1.  Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress.

Authors:  Szu-Wei Lee; Chien-Feng Li; Guoxiang Jin; Zhen Cai; Fei Han; Chia-Hsin Chan; Wei-Lei Yang; Bin-Kui Li; Abdol Hossein Rezaeian; Hong-Yu Li; Hsuan-Ying Huang; Hui-Kuan Lin
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

2.  Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells.

Authors:  Raquel Ordoñez; Anna Fernández; Néstor Prieto-Domínguez; Laura Martínez; Carmen García-Ruiz; José C Fernández-Checa; José L Mauriz; Javier González-Gallego
Journal:  J Pineal Res       Date:  2015-06-08       Impact factor: 13.007

3.  Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma.

Authors:  Zhu Shou; Li Lin; Jia Liang; Jing-Li Li; Hong-Yan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-31       Impact factor: 4.553

4.  Expression of SGTA correlates with prognosis and tumor cell proliferation in human hepatocellular carcinoma.

Authors:  Cuihua Lu; Guoliang Liu; Xiaopeng Cui; Jing Zhang; Lixian Wei; Yingying Wang; Xiaojing Yang; Yanhua Liu; Xia Cong; Liting Lv; Runzhou Ni; Xiaodong Huang
Journal:  Pathol Oncol Res       Date:  2013-07-10       Impact factor: 3.201

Review 5.  Recent advances in SCF ubiquitin ligase complex: Clinical implications.

Authors:  Nana Zheng; Quansheng Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-05-05

Review 6.  Skp2: a novel potential therapeutic target for prostate cancer.

Authors:  Zhiwei Wang; Daming Gao; Hidefumi Fukushima; Hiroyuki Inuzuka; Pengda Liu; Lixin Wan; Fazlul H Sarkar; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2011-09-22

Review 7.  Forkhead box class O transcription factors in liver function and disease.

Authors:  Irina Tikhanovich; Josiah Cox; Steven A Weinman
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

8.  Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity.

Authors:  Qiusha Tang; Mudan Lu; Huan Zhou; Daozhen Chen; Lu Liu
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

Review 9.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

10.  Mechanisms of doxorubicin resistance in hepatocellular carcinoma.

Authors:  Josiah Cox; Steven Weinman
Journal:  Hepat Oncol       Date:  2016-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.